Azzad Asset Management Inc. ADV Makes New Investment in The Clorox Company (NYSE:CLX)

Azzad Asset Management Inc. ADV bought a new position in shares of The Clorox Company (NYSE:CLX - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 19,703 shares of the company's stock, valued at approximately $2,901,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Redwood Park Advisors LLC acquired a new stake in shares of Clorox in the fourth quarter valued at $26,000. Millstone Evans Group LLC bought a new position in shares of Clorox during the 4th quarter valued at about $31,000. Wood Tarver Financial Group LLC bought a new stake in shares of Clorox in the 4th quarter worth approximately $31,000. Asset Planning Inc bought a new stake in Clorox during the fourth quarter worth approximately $32,000. Finally, GKV Capital Management Co. Inc. acquired a new position in Clorox in the fourth quarter worth approximately $32,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on CLX shares. Citigroup cut their price objective on Clorox from $165.00 to $150.00 and set a "neutral" rating for the company in a research report on Monday, April 14th. Wells Fargo & Company reduced their target price on Clorox from $145.00 to $142.00 and set an "equal weight" rating for the company in a report on Tuesday, May 6th. Morgan Stanley dropped their price target on Clorox from $165.00 to $150.00 and set an "equal weight" rating on the stock in a research note on Tuesday, May 6th. Evercore ISI set a $140.00 price objective on shares of Clorox and gave the company an "underperform" rating in a research note on Tuesday, May 6th. Finally, UBS Group decreased their target price on shares of Clorox from $176.00 to $154.00 and set a "neutral" rating for the company in a report on Thursday, April 17th. Three analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has issued a buy rating to the stock. According to MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $151.23.

Insider Activity

In other Clorox news, Director Pierre R. Breber acquired 4,000 shares of the firm's stock in a transaction that occurred on Wednesday, May 7th. The stock was purchased at an average cost of $136.57 per share, for a total transaction of $546,280.00. Following the completion of the acquisition, the director now owns 4,000 shares of the company's stock, valued at approximately $546,280. This trade represents a ∞ increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.57% of the stock is owned by insiders.

Clorox Stock Down 1.5%

NYSE CLX traded down $1.81 on Tuesday, reaching $122.12. The stock had a trading volume of 1,273,433 shares, compared to its average volume of 1,523,994. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The Clorox Company has a 1 year low of $121.98 and a 1 year high of $171.37. The business has a 50 day moving average price of $134.66 and a 200 day moving average price of $147.91. The company has a market capitalization of $15.05 billion, a price-to-earnings ratio of 33.37, a P/E/G ratio of 2.62 and a beta of 0.54.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings data on Monday, May 5th. The company reported $1.45 EPS for the quarter, missing analysts' consensus estimates of $1.57 by ($0.12). The firm had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.74 billion. Clorox had a return on equity of 316.87% and a net margin of 6.38%. The company's quarterly revenue was down 8.0% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.71 EPS. On average, analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.